Bevacizumab offers best value of anti-VEGF drugs to treat DME

Despite recent data showing that aflibercept is the most effective anti–vascular endothelial growth factor (anti-VEGF) treatment available for patients with diabetic macular edema, bevacizumab is...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news